Eddie Warrior Correctional Facility
Taft, Oklahoma, 74463, United States
NCT Number: NCT01413984
The proposed study will evaluate Covington's Helping Women Recover (HWR) plus Beyond Trauma (BT) curriculum with female offenders at Eddie Warrior Correctional Facility in Taft, Oklahoma. The purpose of the proposed study is to expand previous findings by including a comparison group of women that are not receiving treatment but are otherwise eligible, and by using outside evaluators to conduct the assessments. Furthermore, this study will extend the outcomes measured in previous evaluations by including measures of sleep disturbance, posttraumatic cognitions, and a more extensive assessment of trauma-related symptoms. The hypotheses for this study are listed below:
1. Incarcerated women with substance use disorders and history of trauma enrolled in the integrated treatment program (HWR plus BT) will report significantly fewer symptoms on measures of posttraumatic stress and associated cognitions, substance use, depression, and related symptoms following treatment than those in the comparison group. 2. Those in the treatment group will improve significantly more than those in the comparison group on the symptoms listed above.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Taft, Oklahoma, 74463, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Four treatment rounds will be conducted, and a goal of 20 women (10 from each group) will be recruited to participate in each round. A new treatment group will start every four months. Sessions are approximately 2 hours each, 3-4 times per week over four months in a group format. This treatment program will focus on the integrated treatment of trauma and substance abuse in women. Versions of the curriculum exist both for community and corrections populations. In this intervention the corrections version will be used.
Time frame: one-week before treatment, one week post treatment
17 item post traumatic stress disorder symptoms checklist will be administered pre treatment and one week following 4 month treatment completion.
Time frame: one week before treatment, one week post treatment
brief assessment of nightmare frequency and severity to be administered pre-treatment and one week following 4 month treatment completion.
Time frame: one week before treatment, one week post treatment
36 item assesment of cognitions related to world, self and blame to be administered pre-treatment and one week following 4 month treatment completion.
Time frame: one week before treatment, one week post treatment
Center for Epidemiologic Studies Depression Scale (CES-D), NIMH is a 20 item depression inventory to be administered pre-treatment and one week following 4 month treatment completion.
Time frame: one week before treatment, one week post treatment
50 item assessment of alcohol and drugs self efficacy to be administered pre-treatment and one week following 4 month treatment completion.
Time frame: one week before treatment, one week post treatment
100 item trauma symptoms questionnaire to be administered pre-treatment and one week following 4 month treatment completion.
Time frame: one week before treatment, one week post treatment
two scales from the PSI and selected parenting issues from incarcerated women to be administered pre-treatment and one week following 4 month treatment completion.
University of Tulsa
Other
Substance Abuse and Trauma in Incarcerated Women: An Effectiveness Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00431847
Anxiety Disorders, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01859000
Chemically-Induced Disorders, Families
Miami, Florida, United States
View Trial DetailsNCT03458039
Anxiety, Anxiety Disorders
Lusaka, Zambia
View Trial DetailsNCT00656344
Chemically-Induced Disorders, Mental Disorders
New York, United States
View Trial Details